Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
U.S. stocks rose, Nasdaq gained ~400 points. Moderna jumped 9.1% on strong Q3 results and higher FY26 guidance; other stocks rallied on results and deals.
Stocks · News reference
Guggenheim Maintains Buy on JFrog, Raises Price Target to $125
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Piper Sandler Maintains Neutral on JFrog, Raises Price Target to $95
Keybanc Maintains Overweight on JFrog, Raises Price Target to $118
Truist Securities Adjusts Price Target on JFrog to $120 From $115
Truist Securities has raised its price target for JFrog Ltd. from $115 to $120 while maintaining a Buy rating on the stock.
JFrog Ltd. Reports Q3 2026 Financial Results
JFrog Ltd. announced its third-quarter 2026 financial results, reporting revenue of $179.2 million and adjusted EPS of $0.32, both exceeding analyst expectations.
JFrog Launches Universal Zero-Touch Remediation
JFrog has introduced a new Universal Zero-Touch Remediation capability designed to bridge the patching gap by integrating leading patching vendors into a single source of truth.